Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells

The clinical success of EGFR inhibitors in patients with lung cancer is limited by the inevitable development of treatment resistance. Here, we show that inhibition of SREBP increase gefitinib sensitivity in vitro and in vivo. Interference of SREBP1 binding partner MARVELD1 potentiate the therapeutic effect of gefitinib as well. Mechanistically, SREBP inhibition decreases the cell membrane fluidity, results in a decreased tyrosine phosphorylation of EGFR. Therefore, targeting lipid metabolism combined with EGFR-TKIs is potentially a novel therapeutic strategies for cancer treatment.

[1]  X. Zhao,et al.  p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A , 2016, Oncogene.

[2]  G. Huang,et al.  Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth. , 2016, Cancer research.

[3]  Xiaoping Zhou,et al.  Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation , 2015, Molecular Cancer.

[4]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[5]  O. Topolcan,et al.  Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation , 2015, Tumor Biology.

[6]  Xiaoping Zhou,et al.  Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel , 2013, PloS one.

[7]  M. Tan,et al.  Targeting cellular metabolism to improve cancer therapeutics , 2013, Cell Death and Disease.

[8]  Jie Zhou,et al.  Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis , 2012, Cell cycle.

[9]  H. Zhang,et al.  MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma , 2012, Cancer science.

[10]  Timothy F. Osborne,et al.  SREBPs: metabolic integrators in physiology and metabolism , 2012, Trends in Endocrinology & Metabolism.

[11]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.

[12]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[13]  Bo-Liang Li,et al.  Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. , 2011, Cell metabolism.

[14]  K. D. Kikawa,et al.  Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. , 2010, Carcinogenesis.

[15]  P. Harari,et al.  Understanding resistance to EGFR inhibitors—impact on future treatment strategies , 2010, Nature Reviews Clinical Oncology.

[16]  Ziwei Gu,et al.  A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. , 2009, Chemistry & biology.

[17]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[18]  Xianlin Han,et al.  Epidermal Growth Factor Receptors Are Localized to Lipid Rafts That Contain a Balance of Inner and Outer Leaflet Lipids , 2005, Journal of Biological Chemistry.

[19]  Christopher M. Adams,et al.  Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs* , 2004, Journal of Biological Chemistry.

[20]  M. Gleave,et al.  Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence , 2004, Cancer Research.

[21]  K. Mikami,et al.  Membrane fluidity and the perception of environmental signals in cyanobacteria and plants. , 2003, Progress in lipid research.

[22]  G. Ge,et al.  Effect of membrane fluidity on tyrosine kinase activity of reconstituted epidermal growth factor receptor. , 2001, Biochemical and biophysical research communications.

[23]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[24]  B. Maresca,et al.  Does the membrane's physical state control the expression of heat shock and other genes? , 1998, Trends in biochemical sciences.